Home/Filings/4/0001641172-25-026395
4//SEC Filing

Cappello Joseph 4

Accession 0001641172-25-026395

CIK 0001231457other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:15 PM ET

Size

20.9 KB

Accession

0001641172-25-026395

Insider Transaction Report

Form 4
Period: 2025-09-01
Cappello Joseph
VP, Pharmaceutical Development
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-09-0116,6660 total
    Exercise: $6.00Exp: 2026-12-30Common stock (16,666 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-09-0180,0000 total
    Exercise: $6.00Exp: 2027-09-12Common stock (80,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-09-01+80,00080,000 total
    Exercise: $3.33Exp: 2027-09-12Common stock (80,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-09-01+13,33313,333 total
    Exercise: $3.33Exp: 2030-09-23Common stock (13,333 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-09-01+65,00065,000 total
    Exercise: $3.33Exp: 2033-09-10Common stock (65,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-09-0165,0000 total
    Exercise: $22.40Exp: 2033-09-10Common stock (65,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-09-01+16,66616,666 total
    Exercise: $3.33Exp: 2026-12-30Common stock (16,666 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2025-09-0113,3330 total
    Exercise: $6.00Exp: 2030-09-23Common stock (13,333 underlying)
Footnotes (3)
  • [F1]The shares subject to these options are fully vested.
  • [F2]The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options.
  • [F3]The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.

Documents

1 file

Issuer

GENELUX Corp

CIK 0001231457

Entity typeother

Related Parties

1
  • filerCIK 0001939198

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:15 PM ET
Size
20.9 KB